---
figid: PMC7348626__f85-03-9780323430449
figlink: pmc/articles/PMC7348626/figure/f0020/
number: F85
caption: The COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity reducing
  and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic acid (GA)
  to NSAIDs/DMARDs. TNF, Tumor necrosis factor; IL, interleukin; RA FLS, rheumatoid
  arthritis fibroblast-like synoviocytes; COX, cyclooxygenase; TxA2, thromboxane A2;
  TP, thromboxane A2 receptor; PGH2, prostaglandin H2; PGE2, prostaglandin E2; NSAIDs,
  nonsteroidal anti-inflammatory drugs; DMARDs, disease modifying antirheumatic drugs;
  NF-κB, nuclear factor κB; CREB, cAMP response element-binding protein; MAPKs, mitogen
  activated protein kinases; PI3K, phosphoinositide-3-kinase; VEGF, vascular endothelial
  growth factor; ACTN1, α-actinin-1; MMPs, matrix metalloproteinase.
pmcid: PMC7348626
papertitle: Glycyrrhiza glabra (Licorice).
reftext: Michael T. Murray. Textbook of Natural Medicine. 2020 :641-647.e3.
pmc_ranked_result_index: '24638'
pathway_score: 0.6751384
filename: f85-03-9780323430449.jpg
figtitle: COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity reducing
  and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic acid (GA)
  to NSAIDs/DMARDs
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7348626__f85-03-9780323430449.html
  '@type': Dataset
  description: The COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity
    reducing and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic
    acid (GA) to NSAIDs/DMARDs. TNF, Tumor necrosis factor; IL, interleukin; RA FLS,
    rheumatoid arthritis fibroblast-like synoviocytes; COX, cyclooxygenase; TxA2,
    thromboxane A2; TP, thromboxane A2 receptor; PGH2, prostaglandin H2; PGE2, prostaglandin
    E2; NSAIDs, nonsteroidal anti-inflammatory drugs; DMARDs, disease modifying antirheumatic
    drugs; NF-κB, nuclear factor κB; CREB, cAMP response element-binding protein;
    MAPKs, mitogen activated protein kinases; PI3K, phosphoinositide-3-kinase; VEGF,
    vascular endothelial growth factor; ACTN1, α-actinin-1; MMPs, matrix metalloproteinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - IL1B
  - IL17A
  - AKT1
  - TBXAS1
  - ACTN1
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - IL18
  - IL6
  - Glycyrrhizin
  - Glycyrrhetinic acid
  - PGE2
  - TXA2
  - RA
genes:
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Il-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: Il-17
  symbol: IL-17
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TXAS
  symbol: TXAS
  source: hgnc_alias_symbol
  hgnc_symbol: TBXAS1
  entrez: '6916'
- word: ACTN1
  symbol: ACTN1
  source: hgnc_symbol
  hgnc_symbol: ACTN1
  entrez: '87'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-18,6,17
  symbol: IL-17
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: IL-18,6,17
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-18,6,17
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: Glycyrrhizin
  source: MESH
  identifier: D019695
- word: Glycyrrhetinic acid
  source: MESH
  identifier: D006034
- word: PGE2
  source: MESH
  identifier: D015232
- word: TXA2
  source: MESH
  identifier: D014148
diseases:
- word: RA
  source: MESH
  identifier: D001172
figid_alias: PMC7348626__F85
redirect_from: /figures/PMC7348626__F85
figtype: Figure
---
